FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
There is no data about the effects of Renin angiotensin system blockage (RAS) on FGF23 and
ADMA levels in diabetic patients with proteinuria. The aim of this study was to find out
whether the beneficial effects of RAS blockage in diabetic proteinuria has any relation with
the alteration of ADMA and FGF-23 levels. We searched for the effects of ACE inhibitor
ramipril on the clinical and laboratory parameters of diabetic patients with proteinuria.